Tergus Pharma, LLC
US H-1B Labor Condition Application activity for Tergus Pharma, LLC. Filed 74 disclosures between FY2013 and FY2026 from worksites with a NC headquarters indicator.
H-1B outcome breakdown
Share of Tergus Pharma, LLC’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
| Outcome | Share |
|---|---|
| Certified | 86.5% |
| Cert-withdrawn | 12.2% |
| Withdrawn | 1.4% |
Top occupations sponsored
SOC codes filed most by Tergus Pharma, LLC across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 19-2031 | Chemists | 57 |
| 2 | 19-1021 | Biochemists and Biophysicists | 3 |
| 3 | 11-3021 | Computer and Information Systems Managers | 2 |
| 4 | 15-2031 | Operations Research Analysts | 2 |
| 5 | 29-1051 | Pharmacists | 2 |
| 6 | 19-1029 | Biological Scientists, All Other | 1 |
| 7 | 11-3051 | Industrial Production Managers | 1 |
| 8 | 11-9041 | Architectural and Engineering Managers | 1 |
| 9 | 13-1041 | Compliance Officers | 1 |
| 10 | 13-1111 | Management Analysts | 1 |
H-1B filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2013 | 4 |
| FY2014 | 7 |
| FY2015 | 5 |
| FY2016 | 11 |
| FY2017 | 10 |
| FY2018 | 13 |
| FY2019 | 2 |
| FY2020 | 1 |
| FY2023 | 6 |
| FY2024 | 7 |
| FY2025 | 5 |
| FY2026 | 3 |
| Period | Value |
|---|---|
| FY2013 | 4 |
| FY2014 | 7 |
| FY2015 | 5 |
| FY2016 | 11 |
| FY2017 | 10 |
| FY2018 | 13 |
| FY2019 | 2 |
| FY2020 | 1 |
| FY2023 | 6 |
| FY2024 | 7 |
| FY2025 | 5 |
| FY2026 | 3 |
This employer filed at least one WARN Act notice in the last 24 months — a state-mandated advance announcement of a planned mass layoff or closure. A notice is an announcement, not a completed layoff, and it is not evidence of any link between the employer’s H-1B filings and its workforce plans.